Notice: This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) News Today Add Compare Share Share Headlines Stock AnalysisDividendHeadlinesHoldingsRatingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge FundsNovember 23, 2024 | msn.comBuy Rating Affirmed for TScan Therapeutics Amid Positive Developments in TCR-T Cell Therapy SpaceOctober 12, 2024 | markets.businessinsider.comSummit Therapeutics: Positive Data Leads To Targeting Of Other NSCLC SubpopulationSeptember 9, 2024 | seekingalpha.comRange Oncology Therapeutics Index ETF (CNCR)August 15, 2024 | finance.yahoo.comTango Therapeutics Shuts Early-Stage Cancer Study Due To Liver ToxicityMay 23, 2024 | msn.comIntensity Therapeutics: A Bargain For A Late-Stage Company With A Remarkable Oncology DrugMay 14, 2024 | seekingalpha.comPromising Clinical Trials and Strong Financial Position Support Buy Rating for Context TherapeuticsMay 10, 2024 | markets.businessinsider.comRing Therapeutics Presents New Data on Anellogy™ Platform at the 27th Annual American Society of Gene & Cell Therapy ConferenceMay 7, 2024 | markets.businessinsider.comBuy Rating for CytomX Therapeutics on Promising CX-904 Probody Therapy ProspectsMay 6, 2024 | markets.businessinsider.comLarge-scale study explores genetic link between colorectal cancer and meat intakeMarch 15, 2024 | msn.comMicrobix Unveils Test Controls for Head and Neck CancerMarch 11, 2024 | markets.businessinsider.comThe Zacks Analyst Blog Highlights CRPT, CNCR, WISE, AIRR and PKBMarch 3, 2024 | nasdaq.comFDA approval of cancer treatment provides new weapon against tumorsFebruary 22, 2024 | msn.comA watershed moment for cancer therapies has arrivedFebruary 21, 2024 | msn.comETF S.S.-LONCAR CAN.I.ETF (E18B.BE)February 5, 2024 | nz.finance.yahoo.comWhy Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?January 24, 2024 | msn.comTScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent ProgressJanuary 4, 2024 | markets.businessinsider.comLocalized genetic mutations may serve as biomarker for wide range of cancersDecember 21, 2023 | msn.com12 Most Promising Cancer Stocks According to AnalystsDecember 18, 2023 | uk.finance.yahoo.comKorro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 MillionNovember 3, 2023 | markets.businessinsider.comGenerate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AINovember 1, 2023 | businesswire.comGPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100October 26, 2023 | markets.businessinsider.comEXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATIONOctober 23, 2023 | finance.yahoo.comFDA Raises Concerns About Cell Therapeutics' Cancer DrugOctober 20, 2023 | thestreet.comKura Oncology's Head & Neck Cancer Candidate Shows Meaningful Antitumor Activity In Pretreated PatientsOctober 18, 2023 | markets.businessinsider.comTriple Negative Breast Cancer Market Size in the 7MM is expected to change during the study period 2019-2032, estimates DelveInsightOctober 4, 2023 | benzinga.comNektar in collaboration to evaluate non-small cell lung cancer candidateSeptember 27, 2023 | seekingalpha.comMerck Gets CHMP Backing for Keytruda as Non-Small Cell Lung Cancer Adjuvant >MRKSeptember 15, 2023 | marketwatch.comWhy Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?September 11, 2023 | benzinga.comWhy Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?September 7, 2023 | markets.businessinsider.comETF Series Solutions Trust - Range Cancer Therapeutics ETFSeptember 6, 2023 | money.usnews.comCanaccord Genuity Maintains BioXcel Therapeutics (BTAI) Buy RecommendationAugust 16, 2023 | nasdaq.comBest & Worst Sector ETFs of First-Half 2023June 28, 2023 | uk.style.yahoo.comCNCR - Loncar Cancer Immunotherapy ETFMay 25, 2023 | finance.yahoo.comNew Computational Tool Identifies Novel Targets for Cancer ImmunotherapyMay 20, 2023 | markets.businessinsider.comWhere to Be in ETFs for Rising Biotech M&AMay 11, 2023 | nasdaq.comLoncar Cancer Immunotherapy ETF (NASDAQ:CNCR), Quotes and News SummaryApril 14, 2023 | benzinga.comCNCR Loncar Cancer Immunotherapy ETFMarch 24, 2023 | seekingalpha.comSurgery First for Colon Cancer? Not So Fast, According to New Study in JNCCNJanuary 11, 2023 | markets.businessinsider.comATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer CellsJanuary 9, 2023 | markets.businessinsider.comHow to invest, profit and give back using ETFsDecember 5, 2022 | theglobeandmail.comETFs to Watch: Crypto, earnings reports, Treasury yields and moreNovember 14, 2022 | seekingalpha.comWisdomTree Exec on Spot Bitcoin ETF Rejection: No Silver Bullet to AddressOctober 16, 2022 | msn.comHotSpot Therapeutics to Present Preclinical Data from CBL-B Program at 2022 Society for Immunotherapy of Cancer Annual MeetingOctober 7, 2022 | markets.businessinsider.comLung cancer pill outperforms chemotherapy in clinical trialsSeptember 13, 2022 | finance.yahoo.comMount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma PatientsSeptember 1, 2022 | benzinga.comNational Pediatric Cancer Foundation Leads the Fight Against Childhood CancerSeptember 1, 2022 | finance.yahoo.comRoche Reports CE Label Expansion Of VENTANA PD-L1 Assay In Non-small Cell Lung CancerAugust 24, 2022 | markets.businessinsider.comThe Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIOJuly 11, 2022 | finance.yahoo.comPharma & Biotech ETFs at One-Month High: Here's WhyJuly 8, 2022 | finance.yahoo.com Get Range Cancer Therapeutics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… CNCR Media Mentions By Week CNCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNCR News Sentiment▼0.000.58▲Average News Sentiment CNCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNCR Articles This Week▼00▲CNCR Articles Average Week Get Range Cancer Therapeutics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIS News Today IBBQ News Today BIB News Today PSCH News Today PPH News Today IBB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNCR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
